GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Acta2 | decreases expression | ISO | Acta2 (Rattus norvegicus) | 6480464 | CTD | Lipopolysaccharides results in decreased expression of ACTA2 protein | PMID:29775649 | Acta2 | increases expression | ISO | ACTA2 (Homo sapiens) | 6480464 | CTD | Lipopolysaccharides results in increased expression of ACTA2 protein | PMID:31935363 | Acta2 | multiple interactions | ISO | ACTA2 (Homo sapiens) | 6480464 | CTD | 2,5-dimethyl-4-benzoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of ACTA2 protein]; 2-tert-butyl-4-quinone inhibits the reaction [Lipopolysaccharides results in increased expression of ACTA2 protein]; phenylbenzoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of ACTA2 protein]; thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of ACTA2 protein] | PMID:31935363 | Acta2 | multiple interactions | ISO | Acta2 (Rattus norvegicus) | 6480464 | CTD | [sodium arsenite co-treated with Lipopolysaccharides] results in increased expression of ACTA2 mRNA; [sodium arsenite co-treated with Lipopolysaccharides] results in increased expression of ACTA2 protein; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[sodium arsenite co-treated with Lipopolysaccharides] results in increased expression of ACTA2 protein]; SERPINH1 protein promotes the reaction [[sodium arsenite co-treated with Lipopolysaccharides] results in increased expression of ACTA2 mRNA] | PMID:35963424 | |
Go Back to source page | Continue to Ontology report |